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Background: The European Regional Office of the World Health Organization (WHO/Europe) developed a strategic
approach to halt the indigenous transmission of measles in its 53 Member States by 2015. In view of the goal of
measles elimination, it is of great importance to assess the circulation of wild-type measles virus (MV). Genetic
analysis is indispensable to understand the epidemiology of measles.
Methods: Urine and saliva samples were collected between May 2002 and December 2007, in order to find the
origins and routes of wild type measles virus circulation. RT-PCR was performed on a total of 414 clinical samples of
patients from different Italian regions. The results confirmed the genome presence in 199 samples, out of which
179 were sequenced. The sequences were genotyped by comparing the fragment coding for the carboxyl terminus
of the nucleoprotein (450 nucleotides) with that one of the WHO reference strains.
Results: From the year 2002 to the year 2007 phylogenetic analysis of measles sequences showed a predominant
circulation of the D7 genotype in the Italian territory for the years 2002–2004. This genotype was replaced by D4
and B3 genotypes in the biennium 2006–2007. During the same period C2, A, D5 and D8 genotypes were also
detected.
Conclusions: Genetic characterization of wild-type MV provides a means to study the transmission pathways of the
virus, and is an essential component of laboratory-based surveillance. Knowledge of currently circulating measles
virus genotype in Italy will help in monitoring the success of the measles elimination programme and will
contribute to evaluate the effectiveness of future vaccination campaigns.
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Globally, measles morbidity and mortality rates have been
dramatically reduced since 1963, as a result of the availabil-
ity of a safe and effective vaccine and the implementation
of enhanced vaccination strategies [1-3]. Interruption of in-
digenous transmission of measles virus (MV) (Paramyxovir-
idae; Morbillivirus) has been reported for several countries
[4]. Nonetheless, measles remains a leading cause of child-
hood mortality worldwide, with an estimated 164,000 mea-
sles deaths in 2008 (a 78% reduction compared to mortality
rate in 2000), most of which took place in developing coun-
tries, primarily because of underutilization of the vaccine
[5,6]. Furthermore, large outbreaks continue to occur in* Correspondence: fabio.maguranos@iss.it
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distribution, and reproduction in any mediumcountries with high vaccination coverage, after importation
of the virus from endemic regions [7]. WHO measles elim-
ination plan in the European Region (EUR) is targeted by
2015 [1]; thus, progress in measles control in this region is
fundamental for the success of the measles elimination
programme [8]. In 2002–2003, Italy experienced a large
measles outbreak affecting mostly the Southern regions,
with an estimated national incidence of 738/100,000 in
2002 and 544/100,000 in 2003, in children below 15 years
of age, corresponding to over 100,000 estimated cases in
this age group [9-11]. The outbreak was due to poor
measles vaccination coverage. In fact, in 2003 the Italian
national rate of children vaccinated with one dose of
measles-containing vaccine by 24 months of age was 77%,
being significantly lower in Southern regions compared to
Central and Northern areas [12,13].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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During a six-year period (2001–2006) an average of ap-
proximately 5,400 cases was reported annually, with a
range from 18,020 cases in 2002, to 215 cases in 2005.
According to the National Elimination Plan, sensitivity,
specificity, and timeliness of case reporting had to be
improved. Therefore, in April 2007 an enhanced surveil-
lance system was established [14], and a National Refer-
ence Laboratory (NRL) was established at the Istituto
Superiore di Sanità (ISS) in order to support cases ascer-
tainment, confirm outbreaks/cases and determine the
MV genotypes.
Molecular epidemiology, i. e. genetic characterization of
wild-type MVs combined with standard epidemiological
methods, is an essential component of the laboratory-
based surveillance. It is performed throughout the world
by the WHO Measles and Rubella Laboratory Network,
which serves 166 countries in all WHO regions. Virological
surveillance has helped to document the interruption of
transmission of endemic measles in some regions. It
includes epidemiological investigation and laboratory con-
firmation of all sporadic illnesses clinically consistent with
measles. Moreover, laboratory-based surveillance forPiedim
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Figure 1 Geographical distribution of measles virus (MV) genotypes i
and 2007 (B).measles and rubella, including genetic characterization of
wild-type viruses, permits to illustrate the progress towards
measles elimination by differentiating viruses between indi-
genous and imported. Molecular characterization of mea-
sles viruses provides a valuable tool to measure the
effectiveness of measles control programmes, and viro-
logical surveillance needs to be expanded throughout the
world, and conducted during all phases of measles control.
Genetic characteristics of representative wild-type MVs,
identified in Italy between 2003 and 2007, were analyzed
in this study.
Results
Urine and saliva samples were collected between May
2002 and December 2007 (Figure 1) in order to find ori-
gins and routes of MV wild-type circulation. RT-PCR
(reverse transcriptase polymerase chain reaction) was
performed on a total of 414 clinical samples, 399 urine
and 15 saliva respectively, collected from different Italian
regions and coming from 414 patients. The results con-
firmed the presence of the genome in 199 samples, out
of which 179 were sequenced (Table 1). The sequences
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tides) with the one of the WHO reference strains. A rep-
resentative set of sequences is listed in Table 2.
The results of genetic analysis indicated that 21 out of
23 specimens sequenced in 2002, either before or during
the peak of the outbreak, belonged to genotype D7 and
2 to genotype A (Figure 2). All the 21 sequences classi-
fied as genotype D7 were closely related to each other,
showing overall only a single nucleotide difference. This
fact supports the hypothesis of a common origin of the
epidemic. Furthermore, these strains showed a 100% iden-
tity with those isolated in France in 2001 and 2003 (MVi/
Paris.FR/01/1, MVi/Lyon.FR/03/1), in Germany in 2000
and 2001 (MVs/Mainz.DEU/06.00/1, MVi/Mainz.DEU/
07.01), in Canada in 2000 (MVs/Alberta.CAN/20.00/1),
and in Belarus in 2003 (MVs/Minsk.BLR/17.03), and were
99% identical to the MV D7 reference strain MVi/Illinois.
USA/50.99.
During 2003, 7 specimens were sequenced: all of them
belonged to genotype D7. All these sequences were
closely related to each other, showing 99-100% identity
with the D7 strains circulating in Italy in 2002, and with
the strains circulating in Europe during the years 2000–
2003 (Figure 2).
During 2004, 4 specimens were sequenced: 3 of them
belonged to the genotype C2 and 1 to genotype A. MVs
strains belonging to the genotypes C2 circulated in
Germany in 1992, in Spain during 1992–1993, and in
Great Britain during 1992–1995, suggesting a wide dis-
tribution of this genotype throughout Europe. More
recently, genotype C2 has been detected in Luxembourg
as well as in Germany, the Czech Republic and Denmark;
it was responsible for the epidemic that occurred in
Morocco in 2003. The Italian C2 strain differed for a sin-
gle nucleotide from that one isolated in Luxembourg dur-
ing 1996–1997 [15], as well as from two strains imported
into the USA in 1997–1998 [16], while it differed only for
one nucleotide from the C2 Moroccan strain (Figure 2).
No epidemiological links are available for these strains.
The Italian C2 strains showed a sequence identical to theTable 1 Measles cases tested at the Italian National Reference
related genotypes
N of cases
Year Tested samples RT-PCR positive Sequenced
2002 38 23 23
2003 19 7 7
2004 21 4 4
2005 no data no data no data
2006 127 93 76
2007 209 72 69
TOT 414 199 179Moroccan and Spain strains circulating in 2003 (MVi/
Casablanca.MOR/19.03/2).
All the 3 strains belonging to the genotype A, circulat-
ing in 2002 and 2004, revealed a close relationship with
the vaccine strains: the strains isolated in 2002 showed
identical sequences and the other A strain showed the
90% of identity with the vaccine sequence (Figure 2).
The strains isolated in the period 2002–2004 came from
Campania, Lazio, Umbria Marche and Veneto regions
(Figure 1).
No laboratory data are available for the year 2005 be-
cause of the interruption of the surveillance activity that
restarted in the year 2006.
During 2006, 75 specimens were sequenced. The
phylogenetic analysis showed that 59 sequences out of
76 belonged to genotype D4 and 16 to the genotype B3
(Figure 3).
In 2007, 69 sequences were analyzed; 29 of them
belonged to genotype D4, 35 to genotype B3, 4 to geno-
type D5 and 1 to genotype D8.
Therefore, the majority of MVs circulating between
2006 and 2007 in Central and Northern Italy belonged
to genotype D4 (n= 88), and appeared to be grouped
into two different clusters: D41 (n= 61) and D42 (n= 27),
respectively (Figure 3).
The 73% (44 out of 60) of the D41 sequences were
100% identical to each other; 22% (13 out of 60) differed
from the latter for a single nucleotide; 3% (2 out of 60)
showed overall a difference of three nucleotides, and
1.6% of five nucleotides (1 out of 60).
BLAST analysis in MeaNS database (Measles Nucleo-
tide Surveillance; http://www.who-measles.org) showed
that the D41 cluster sequences were for the 99% identi-
cal to the strains that circulated in Europe and then
imported into the USA in the years 2006 and 2007 [17].
The strains belonging to this cluster were first isolated
in February 2006 and circulated until February 2007 in
Trentino Alto Adige, Lazio [18] and Sardinia regions.
The measles viruses belonging to the cluster D42 were
first isolated in February 2006 and circulated throughoutLaboratory (ISS) during the period 2002–2007, and
Genotypes
A B3 C2 D4 D5 D7 D8
2 - - - - 21 -
- - - - - 7 -
1 - 3 - - - -
- - - - - - -
- 16 - 60 - - -
- 35 - 29 4 - 1
3 51 3 89 4 28 1
Table 2 List of the representative sequences analyzed between 2002 and 2007
Year Name of strain1 N of sequences N of weeks2 Genotype GenBank accession number Total
2002 MVs/Roma.ITA/20.02/1 1 1 D7 JQ783051 23
MVs/Roma.ITA/20.02/2 3 6 D7 JQ783052
MVs/Ancona.ITA/26.02 1 1 D7 JQ783050
MVs/Caserta.ITA/27.02/1 5 1 D7 JQ783049
MVs/Caserta.ITA/27.02/2 1 1 A JQ783038
MVs/Ascoli.ITA/27.02/1 8 4 D7 JQ783048
MVs/Ascoli.ITA/30.02/5 1 1 A JQ783039
MVs/Ancona.ITA/45.02 3 1 D7 JQ783047
2003 MVs/CastelfrancoVeneto.ITA/09.03 1 1 D7 JQ783040 7
MVs/Roma.ITA/09.03 1 1 D7 JQ783041
MVs/Avezzano.ITA/14.03 1 1 D7 JQ783042
MVs/Roma.ITA/15.03 1 1 D7 JQ783043
MVs/Pistoia.ITA/23.03 1 1 D7 JQ783044
MVs/Pordenone.ITA/19.03/1 1 1 D7 JQ783045
MVs/Pordenone.ITA/19.03/2 1 1 D7 JQ783046
2004 MVs/Todi.ITA/28.04/1 3 1 C2 EF490999.1 4
MVs/Todi.ITA/28.04/4 1 1 A EF469771.1
2006 MVs/Merano.ITA/33.06 2 1 D41 AM849094.1 75
MVs/Roma.ITA/33.06/1 38 18 D41 EF533887.1
MVs/Latina.ITA/35.06 7 7 D41 JQ783032
MVs/Alghero.ITA/36.06 3 2 D41 JQ783033
MVs/Roma.ITA/36.06 6 4 D41 JQ783034
MVs/Roma.ITA/37.06/7 1 1 D41 JQ783035
MVs/Pescara.ITA/39.06 1 1 D41 JQ783036
MVs/Roma.ITA/43.06/2 9 10 B3.1 EF533886.1
MVs/Roma.ITA/45.06/2 1 1 D41 JQ783037
MVs/Pomezia.ITA/48.06/1 2 4 B3.1 JQ783028
MVs/Albano.ITA/48.06 3 2 B3.1 JQ783029
MVs/Aprilia.ITA/49.06 1 1 B3.1 JQ783030
MVs/Latina.ITA/50.06 1 1 B3.1 JQ783031
2007 MVs/Roma.ITA/01.07 8 14 B3.1 JQ783008 69
MVs/Roma.ITA/02.07 1 1 B3.1 JQ783009
MVs/Barletta.ITA/03.07 1 1 B3.1 JQ783010
MVs/CapoD'Orlando.ITA/04.07 1 1 B3.1 JQ783011
MVs/Latina.ITA/07.07 1 1 B3.1 JQ783012
MVs/Salerno.ITA/07.07 1 1 D41 JQ782998
MVs/Merano.ITA/07.07 1 1 D41 JQ782999
MVs/Milano.ITA/09.07 1 1 D42 JQ783007
MVs/Roma.ITA/10.07/1 5 5 B3.1 JQ783013
MVs/Roma.ITA/10.07/3 1 1 B3.1 JQ783014
MVs/Grosseto.ITA/11.07 1 1 B3.1 JQ783015
MVs/Parma.ITA/11.07 7 9 B3.1 JQ783016
MVs/Milano.ITA/11.07 1 1 B3.1 JQ783017
MVs/Viterbo.ITA/11.07 1 1 B3.1 JQ783018
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Table 2 List of the representative sequences analyzed between 2002 and 2007 (Continued)
MVs/Roma.ITA/12.07 1 1 D8 JQ783053
MVs/Roma.ITA/13.07 3 1 D42 JQ783006
MVs/Ancona.ITA/13.07 3 4 B3.1 JQ783019
MVs/Viterbo.ITA/13.07 1 1 B3.1 JQ783020
MVs/Ferrara.ITA/15.07 1 1 B3.1 JQ783021
MVs/Bari.ITA/21.07 1 1 B3.1 JQ783022
MVs/Padova.ITA/23.07 1 1 B3.1 JQ783023
MVs/Bolzano.ITA/38.07 1 1 D5 JQ783027
MVs/Lodi.ITA/38.07 1 1 D5 JQ783025
MVs/Roma.ITA/38.07 1 1 D5 JQ783024
MVs/Bologna.ITA/39.07 1 1 D5 JQ783026
MVs/Cuneo.ITA/41.07 12 7 D42 JQ783005
MVs/Milano.ITA/41.07/2 1 1 D42 JQ783004
MVs/Cuneo.ITA/46.07 7 1 D42 JQ783003
MVs/Trento.ITA/47.07/1 1 1 D42 JQ783002
MVs/Trento.ITA/47.07/2 1 1 D42 JQ783001
MVs/Torino.ITA/51.07/1 1 1 D42 JQ783000
1: The nomenclature indicates the geographical origin and the year in which each virus was first identified. Identical sequences collected in the same place were
grouped, and a single representative sequence was submitted in GenBank.
2: Period of circulation of each strain from its first isolation.
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Piedmont, Lazio and Sardinia regions (Figure 1). These
sequences showed a maximum difference of 2 nucleo-
tides (≤0.5%), difference that remained unchanged when
the strains MVi/Kolar.IND/03.07/1 and MVs/London.
GBR/25.07 were added to the alignment, while it showed
an increase with the addition of the strain MVs/Gros-
seto.ITA/a301 [19].
Instead, the 51 B3 strains, isolated during the biennium
2006–2007, belonged to the subgroup B3.1 (Figure 3) [20].
The genetic diversity of all these B3.1 circulating strains
was limited to a maximum difference of 4 nucleotides
(≤0.99%). In addition, the genetic analysis revealed that
some of these Italian cases were also identical to a case
from Albania in 2006 (MVi/Shkodra.ALB/44.06), and to a
case from Great Britain in 2005 (MVs/London.GBR/
31.05). The sequences belonging to B3.1 genotype were
first isolated in October 2006 and the relevant strains cir-
culated until June 2007 in Veneto, Lombardy, Emilia
Romagna, Tuscany, Marche, Lazio, Abruzzo, Apulia and
Sicily regions.
Discussion
This study stands so far as the first description of the
molecular epidemiology of MV in Italy.
Before this study the information about strains circu-
lating in Italy derived from some cases occurred in
Italy and imported into the U.S.A., Great Britain and
Luxembourg [21,22]. The genotypes described were D6
(1996–97) and D8 (1999).In our study we found that 28 (82%) out of the 34 MV
sequences detected from clinical specimens during
2002–2004 belonged to genotype D7. Three (9%) were
placed in genotype C2 and three (9%) were placed in
genotype A (Figure 2).
The results of our analysis indicate that genotype D7
was the cause of the epidemic that occurred in 2002,
and probably of the one occurred in 2003, with 18,020
and 11,978 measles confirmed cases, respectively. There-
fore, genotype D7 was the endemic MV in the years 2002
and 2003. The sequence analysis of the Italian cases
showed that all the strains identified were strongly related
to each other, and closely related to the European strains.
Genotype D7 circulated in Great Britain and in Australia
during the 1980s [23,24]. Chains of transmission of this
genotype have been associated, through epidemiological
investigations, to Sweden and other European countries
[25]. In the early 2000s, this genotype replaced the geno-
types C2 and D6, becoming the most commonly isolated
genotype in Germany and France [26,27]. This shift was
demonstrated in Germany during 2000–2001 [28]. Geno-
types shift takes place in those countries where the inter-
ruption of endemic transmission occurs only for short
periods, due to measles sub-optimal control programmes.
Indeed, failure in maintaining high levels of population
immunity results in the accumulation of susceptible indivi-
duals, thus creating favourable conditions for a rapid trans-
mission of a newly introduced genotype.
The comparison of the Italian A genotype MVs with
those deposited in Means database revealed a close
Figure 2 Phylogenetic analysis according to the partial sequence of the N gene of measles virus (MV) strains identified in Italy, from
2002 to 2004. Numbers in parenthesis indicate the number of additional identical strains from the same region. Significant bootstrap values
(>80%) are indicated.
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Figure 3 Phylogenetic analysis according to the partial
sequence of the N gene of measles virus (MV) strains identified
in Italy, in the biennium 2006–2007. Numbers in parenthesis
indicate the number of additional identical strains from the same
region. Significant bootstrap values (>80%) are indicated. M*: MeaNS
id number.
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well as with the wild-type genotype A strain (Figure 2).
Unfortunately, no information about the vaccination sta-
tus of these patients was available. However, the close
genetic relationship with the vaccine strains indicates
that these cases should be caused by vaccine virus.
Phylogenetic analysis for the sequences of the Italian
cases in the years 2006–2007 revealed a co-circulation of
D4 and B3 genotypes. In addition, we identified an out-
break caused by genotype D5, and only a single case
belonging to D8 genotype in 2007 (Table 2; Figure 3).
Eighty-nine (61%) out of the 145 MV strains detected in
clinical specimens, in the years 2006–2007, belonged to
genotype D4. This genotype was endemic on the Indian
subcontinent, as well as in East and South Africa [25,29].
Genotype D4 has been repeatedly identified in the WHO
Eastern Mediterranean Region [30], as well as in out-
breaks and sporadic cases in several European countries,
including Germany, Turkey, Spain, Great Britain, Croatia
and Russia [17,31,32].
Italian D4 strains grouped into two different clusters
of common origin (Figure 3). The strains belonging to
cluster D41 were isolated from August 2006 to February
2007, and were closely related to the strains circulating
in Europe and USA from late 2005 to early 2007.
According to the analysis made by Kremer et al. [17]
these strains belonged to a group described as ‘European
group 1’. Moreover, this group was responsible for a
large outbreak in Romania, which included >8,000 cases
and lasted from December 2004 until early 2007 [17].
D4 Italian strains belonging to cluster D42 were isolated
from November 2006 to December 2007, and were closely
related to the Grosseto strain [19] and to the strains circu-
lating in India, Great Britain and Germany in the same
period. D42 was responsible for the outbreak occurred in
Piedmont in 2007 having been imported from the United
Kingdom [14] and differed from the European groups that
circulated in the biennium 2005–2006 [17].
In 2007 the strain D5 caused a small outbreak in Italy,
and the phylogenetic analysis suggests that it was prob-
ably imported from Japan. In fact, despite unavailability
of epidemiological links, this strain caused an outbreak
in 2007 in Hokkaido district (Japan) [33].
In 2007 we found a single case belonging to the D8
genotype (Figure 3), whose strain has been isolated in
Russian [34] and was endemic in India in the same period
[35] but the source of the virus remained unknown.
From October 2006 to December 2007 the circulation
of B3 strain, the same strain that caused the Apulia out-
break in 2006 [36], was observed with the first case iden-
tified. The strain was identified for the first time in the
Lazio Italian region. This could suggest the place where
the B3 outbreak started, but no epidemiological data
supported this hypothesis.
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specimens in the years 2006–2007 belonged to genotype
B3. All these strains belonged to genotype B3.1 and were
closely related to the strains isolated in Albania, Switzerland
and circulating in Great Britain in the same period, suggest-
ing a possible route of introduction by the latter (Figure 3)
[14] although the origin of B3 outbreak was not known.
In summary, according to our analyses we can assert
that D7 strain was endemic in Italy from 2002 to 2004.
In 2006 it was replaced by D4 and B3 strains that circu-
lated also in 2007.
In conclusion, a continuous improvement of labora-
tory surveillance is needed, particularly of the molecular
laboratory. This is significantly important in countries
where the measles elimination phase, such as Italy, is tak-
ing place and increasing efforts to obtain appropriate spe-
cimens from each chain of transmission are necessary.
Materials and methods
Measles case definitions
Measles cases were clinically defined i.e., generalized rash,
lasting at least 3 days, accompanied by fever > 38°C, and
cough, coryza or conjunctivitis.
Laboratory confirmation was attained by the determin-
ation of measles specific IgM antibodies through enzyme
immunoassay, and/or by the detection of measles virus
genome in saliva or urine by RT and hemi-nested PCR.
Specimens
Oral-fluid specimens were obtained by salivary swabs
(Salivette, Sarstedt Company). Saliva was collected after
centrifugation at 500 g for 10 minutes, and then stored
until tested.
Urine samples were collected within 7 days from rash
onset. Urine sediment was obtained after centrifugation at
500 g for 10 minutes, washed two times in sterile PBS, and
resuspended in a final volume of 0.5-1 ml. Sediments were
stored at −80°C. The tests on urine and salivary samples
were performed under the indications of the “National
Plan of Elimination of Measles and Congenital Rubella”.
The Plan has been elaborated by the Ministry of Health
according with the WHO indications, and approved by all
Regional Health Authorities. Our laboratory belongs to the
WHO European Regional Network of National Measles
and Rubella Reference Laboratories. Goal for this network
is the measles elimination in Europe in 2015. Before col-
lecting samples, subjects, or their parents in case of chil-
dren, had to sign the “informed consensus”. No formal
approval from an ethics committee has been required;
however the study complies with the Helsinki declaration.
RT-PCR amplification and sequencing
Total RNA was extracted using QIAmp Viral RNA Mini
Kit (Qiagen) for saliva samples and RNeasy mini Kit(Qiagen) for urine samples, as per manufacturer proto-
cols. Nucleic acid was tested by RT-PCR using a hemi-
nested protocol [24] directed to a highly conserved part
of the MV RNA, which is located on the N gene. Kit
SuperScript One-Step RT-PCR kit with Platinum Taq
(Invitrogen) was used for RT-PCR reaction.
Nucleotide Sequence Analysis
Both strands of amplified products were sequenced by
Macrogen Inc. (Seoul, Korea), using MVF2 and MVB1
primers.
Genomic sequences of reference strains used for gen-
etic analysis of wild-type measles viruses were obtained
from database by accession number [37,38]. Nucleotide
sequences were aligned with the CLUSTAL W (BioEdit)
software [39]. Phylogenetic trees were constructed using the
nucleotide Kimura-2 parameter and the neighbour-joining
method. Bootstrap analyses were performed through 1,000
resampling of the data sets. The neighbour-joining method
[40] was implemented by using MEGA-5 [41].
The sequences had been submitted to GenBank, and
the corresponding accession numbers are given in Table 1.
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